Volume 27, Number 9—September 2021
Dispatch
Disseminated Cutaneous Leishmaniasis and Alcohol Misuse, Northeast Brazil, 2015–2018
Table 2
Variable | Localized cutaneous leishmaniasis | Disseminated cutaneous leishmaniasis | Odds ratio† | p value |
---|---|---|---|---|
Total |
38 (100.0) |
18 (100.0) |
||
Sex | ||||
M | 35 (92.1) | 16 (88.9) | 1.00 | 0.7 |
F |
3 (7.9) |
2 (11.1) |
1.46 |
|
Age, y‡ | 41 (19–89) | 42 (19–77) | 1.01 | 0.64 |
Diabetes | 3 (7.9) | 3 (16.7) | 2.13 | 0.39 |
Disease duration, wks‡ | 8 (3–26) | 16 (5–36) | 1.17 | <0.01 |
Mucosal lesion | 1 (2.6) | 9 (50.0) | 43.7 | <0.01 |
Parasite load‡§ | 3 (1–340) | 5 (1–556) | 1.002 | 0.53 |
Agricultural occupation | 22 (57.9) | 12 (66.7) | 1.45 | 0.53 |
Daily alcohol intake, g/d‡ | 0 (0–400) | 325 (0–800) | 1.01 | <0.01 |
Days with alcohol intake >28 g | 4 (10.5) | 14 (77.8) | 23 | <0.01 |
*Values are no. (%), except as indicated. DCL, disseminated cutaneous leishmaniasis; LCL, localized cutaneous leishmaniasis. †Estimated by simple logistic regression. ‡Values are median (range). Load measured as the number of intracellular and extracellular amastigotes in 15 high-powered fields (×40) using immunohistochemical assays. §Of 6 LCL patients and 7 DCL patients.
Page created: June 28, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.